Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RECOMB: Truvada Switch for Body Fat Distribution in HIV
NCT00324649Phase 4Completed
- Sponsor
- Gilead Sciences
- Start
- May 2006
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of emtricitabine + tenofovir disoproxil in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Gilead Sciences. Started May 2006; status: completed.
02
Drugs
emtricitabine + tenofovir disoproxil
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00324649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00324649.